In our study, the upregulation of the FN1 signaling pathway between CCL18+ macrophages and endothelial cells, particularly in the non-responder group, indicated their potential role in promoting endothelial cell proliferation and tumor angiogenesis in NSCLC patients. The gene discussed is CCL18; the disease is neoplasm.